RYR1 and breast cancer: Together with Theresa Guise we used a murine model of human breast cancer metastatic to bone to show that TGF-β released from the bone activated a pathway leading to oxidation of RyR1 in the neighboring skeletal muscle, rendering the channels leaky and promoting muscle weakness (50).